To investigate whether energy derived from glycolytic and oxidative metabolism are preferentially used for different functions in heart, tension, intracellular potential, and extracellular [K+] and pH (using triple barrel K/pH electrodes, tip diameter 0.5 mm) were monitored in isolated arterially perfused rabbit interventricular septa during exposure to hypoxia and metabolic inhibitors. Myocardial content of high energy phosphates, lactate, and glycogen were determined under the same conditions. Inhibiting oxidative metabolism with hypoxia, dinitrophenol (10-s M), or Na-azide (10-3 M) caused marked suppression of tension (by 73±5, 65±8, and 50±14%, respectively) and a small increase in [K+]> (0.8±0.4, 0.5±0.25, and 0.4±0.2 mM, respectively) after 10 min. Inhibiting glycolysis with iodoacetate (IAA) (10-3 M) had a much smaller suppressant effect on tension (28±24%) but markedly increased IK'io accumulation (by 1.8±1.1 mM) at 10 min. These differences, when IAA was compared individually to the other interventions, were highly significant. The shortening of action potential duration was not significantly different for the four interventions. pHO increased slightly during IAA (+0.04-+0.06 U) and fell during the other interventions (-0.10--0.16 U), but this did not account for the differences in [K+]J accumulation and tension between inhibition of glycolytic vs. oxidative metabolism. Except for hypoxia, total cellular content of high energy phosphates was not significantly depressed under the various conditions. This data suggests that energy from glycolysis is preferentially used to support sarcolemmal function (as manifested by K+ loss), whereas oxidatively derived energy preferentially supports contractile function.
Introduction
In erythrocytes, evidence has been presented that high energy phosphates generated via glycolysis may be preferentially used to support specific cellular membrane functions (1) . Conversely, in muscle it has been proposed that the creatine phosphate energy shuttle may be the preferential source of high energy Address reprint requests to Dr. Weiss, UCLA Center for the Health Sciences, Los Angeles, CA 90024.
Received for publication 25 June 1984 and in revised form 24 September 1984. phosphates for muscle contraction (2) . In vascular smooth muscle a functional compartmentation of glycolytic vs. oxidative metabolism has been demonstrated recently by Paul (3) , who showed that Na+-K+ pump activity was closely linked to glycolytic flux whereas force development correlated with oxidative metabolism in this preparation. Several lines of evidence suggest that a similar compartmentation of glycolytic energy may exist in cardiac muscle. MacLeod and Daniel (4) found that in anoxic guinea pig papillary muscles, elevated glucose concentration prevented action potential shortening but had no effect on improving contractile force. Bricknell et al. (5, 6) found that during low flow ischemia in isolated rat hearts, enzyme release and the onset of ischemic contracture were greatly accelerated by concomitant inhibition ofglycolysis compared to inhibition of oxidative metabolism, despite similar total cellular levels of high energy phosphates. Higgins and Bailey (7) reported similar results and have also found that susceptibility of cultured heart cells to attack by phospholipases was sensitive to the rate of glycolysis of the cells, but not to inhibition of oxidative ATP production (8) .
Recently, Doorey and Barry (9) and Hasin and Barry (10) reported that in cultured chick embryo myocytes, membrane depolarization was more sensitive to inhibition of glycolytic than oxidative metabolism, whereas contractile amplitude was more affected by inhibition of oxidative metabolism. These studies are compatible with a functional compartmentation of metabolic processes in heart, in which high energy phosphates generated via glycolysis play a special role in the maintenance of cell membrane function, helping to prevent damage to the sarcolemma during ischemia and other interventions interfering with oxidative metabolism. In this report, a comprehensive evaluation of cardiac function in intact ventricular myocardium was made during interventions designed to influence selectively either glycolytic or oxidative metabolism, to determine whether high energy phosphates generated via these metabolic pathways are preferentially used for different functions in cardiac muscle. In particular, since both cellular K+ loss and contractile force are suspected of being directly linked to the metabolic state, the effects of inhibition of glycolytic vs. oxidative metabolism on these parameters were closely examined. Tissue levels of high energy phosphates and other metabolites were also measured under the various conditions. The results support the hypothesis that energy stores are partially compartmentalized in the rabbit ventricle, and demonstrate that manifestations of compartmentation can be elicited in intact ventricular myocardium after brief perturbations of cardiac metabolism.
Methods
Experimental set-up. The preparation was the arterially perfused isolated rabbit interventricular septum. 2-3-kg adult New Zealand white rabbits thoracotomy. After removing the heart, the septal artery was cannulated, and the interventricular septum isolated and mounted in a constant temperature (370C) nitrogen-filled chamber as described previously (11) . A ligature placed at the apex of the preparation was tied to a variable capacitance tension transducer to record tension. The septum was stimulated at 75 bpm with platinum electrodes (series 1800 stimulator, WP Instruments, Inc., New Haven, CT). A perfusion pump (Gilson Minipulse 2) maintained a constant physiologic flow of 1.75 ml/min (1.5-2.5 mug per minm of heated 370C perfusate through the septal artery. Standard perfusate consisted of (in millimolar): NaCl 120, KCI 4, CaCI2 1.5, NafICO3 22, NaH2PO4 0.44, MgCl2 1, dextrose 5.6, and pyruvate 3. Insulin (10 U/l) was added in all experiments. pH was maintained at 7.3-7.4 by gassing with a mixture of 5% CO2 and the balance 02 (control perfusion) or N2 (hypoxia experiments).
In some experiments, 1-2.5 X Ions M 2,4-dinitrophenol (DNP),' lo-3 M sodium azide, 10^-l0-3 M iodoacetate (IAA), or 20 mM 2-deoxyglucose were added to the perfusate. Dextrose, but not pyruvate, was excluded from perfusate containing iodoacetate or 2-deoxyglucose. The preparation was allowed to equilibrate at least I h in standard perfusate before experimental intervention. This preparation has been shown to maintain stable mechanical and metabolic function and K+ balance for a period of 5-6 h (12) (13) (14) .
Electrodes. Intracellular potential was recorded with flexibly mounted glass microelectrodes filled with 3 M KC1 (15) . A triple barrel K/pH electrode, overall tip diameter 0.5 mlm, was used to measure extracellular K+ and pH. The K+ barrel (tip diameter 0.2 mm) was constructed by the method of Hill et al. (16) . The solid state pH barrel (0.1 mm diameter) was obtained commercially (Beetrode, WP Instruments, Inc., New Haven, CT). Response time of,both electrodes is of the order of 0.1 s. A reference barrel consisted of teflon-coated Ag wire (0.13 mm diameter) whose tip (I mm) had been exposed and chlorided. The three barrels were tied together using a fine suture. Signals were fed into high impedance (jo03 ohms) preamplifiers and the K+ and pH signals subtracted from the reference barrel signal by differential amplifiers. Each K/pH electrode was calibrated at 370C in at least four solutions of known [KI] and pH before and at the conclusion of each experiment, and the slope was calculated by linear regression analysis.
The K+ barrel and pH barrels typically yielded slopes of 60-61 and 52-57 mV/decade change in concentration, respectively. Interference from other physiological ions was negligible. After insertion in the preparation through a superficial cut in the endocardium, each electrode was calibrated in situ by varying the K+ and pH of the perfusate, and repositioned if the predicted response was not obtained.
Metabolic assays. A separate group of preparations was mounted in the same way as described above; tension was recorded continuously, but no electrophysiological measurements were performed. Venous effluent was collected at timed intervals (20 s collection time per sample) during various interventions and assayed by standard spectrophotometric techniques for lactate content (17) . At the end of the intervention, the pins securing one end of the preparation were removed, and the preparation was lifted off the floor of the chamber using the suture connected to the tension transducer. While still being perfused, the preparation was then smash frozen between copper blocks precooled in liquid N2 and rapidly immersed and stored in liquid N2.
A small portion of the preparation was weighed before and after drying at 1000C to assess dry weight per wet weight ratio (average value 0.13±0.01), and the remainder was extracted with 0.5 M perchloric acid. The value of the dry weight per wet weight ratio was slightly lower than previously reported in nonfreeze clamped septa (12) , which is probably due to trapping of surface water and the full distension of the vascular space at the moment of rapid freezing of the preparation. Experimental protocols. In the electrophysiological experiments, after equilibration, each preparation was exposed to a 10-min episode of hypoxia and allowed to recover for -30 min before the experimental intervention. This was done in order to be able to compare the effect of the intervention to hypoxia in each preparation. If the effects of the intervention were reversible, then a second hypoxic episode was repeated 30 min after recovery from the intervention to assess reproducibility. Changes in tension (normalized with respect to the value immediately preceding the intervention), [K'JO, pH0, and action potential duration were found to be quite reproducible between successive 10-min exposures to hypoxia provided a recovery period of >25 min was permitted between episodes. To be consistent with the electrophysiological experiments, the metabolic experiments followed a similar protocol in which a 10-min period of hypoxia followed by a 30-min recovery period preceeded the intervention being tested.
Data analysis. Analysis of variance with the Bonferroni approach was used to evaluate statistical significance. In the case of data that was normalized (e.g., tension measurements), the logarithms of the normalized data was used in the statistical analysis to avoid overestimation of significance. Data is presented as mean±SD in the text, and mean±SE in the figures for graphical simplicity. that inhibition of glycolysis with 10-3 M IAA resulted in marked K+ loss from the myocardium with a modest suppression of tension. In contrast, inhibition of oxidative metabolism with hypoxia, DNP, or Na azide was associated with only modest K+ loss but a major reduction in tension. These differences were statistically significant (comparing IAA vs. hypoxia, DNP, or Na azide for [K+] o accumulation or tension suppression, P < 0.001). Shortening of action potential duration was modest and similar under all conditions. 10-3 M IAA caused a slight increase in pHo (consistent with reduced glycolytic H+ production), whereas inhibitors of oxidative Table I compare the myocardial levels of ATP, ADP, AMP, phosphocreatine, creatine, lactate, and glycogen after 10 min exposure to each of these interventions. Fig. 7 shows the venous lactate effilux rate as a function of time under each condition. During inhibition of glycolysis with 10-3 M IAA, total cellular content of high energy phosphates was well maintained and was not significantly different from control (Figs. 4 and 5). Tissue lactate and glycogen content were slightly but not significantly reduced (Fig. 6 ). Lactate efflux rate fell to 60±8% of control in the presence of IAA. During inhibition of oxidative metabolism by DNP or Na Azide, tissue content of high energy phosphates was also not significantly different from control. Hypoxia, which produced the greatest reduction in tension, caused a slight fall in ATP (not statistically significant) and a significant decrease in phosphocreatine (P < 0.005) (Figs. 4 and 5). Tissue lactate tended to increase with no real change in glycogen content ( Fig. 6 ), although the great variation in glycogen content between individual preparations was difficult to evaluate. Lactate efflux rate markedly increased in response to all three interventions interfering with oxidative metabolism (Fig. 7) , with the largest increase occurring during hypoxia (506±83% of control after 10 min), followed by DNP (314±42%) and Na Because LAA is not a completely specific metabolic inhibitor, the effects of several other interventions designed to inhibit glycolysis selectively were also studied. These included (a) removal of glucose from the perfusate; (b) removal of glucose and addition of 5 mM Na acetate (19) were not significantly depressed by any of these interventions (Table II Further evidence that these interventions did not completely suppress glycolysis was obtained from experiments in which lactate efflux was monitored during exposure to each regimen for a 20-min period, the last 10 min of which the perfusate was also made hypoxic. As seen in Fig. 10 , none of the interventions, except for l0-3 M IAA, completely prevented the hypoxia-induced increase in lactate efflux. Glucose-free perfusate with acetate present did not suppress the increase in lactate output during hypoxia at all (see Fig. 7 for comparison), whereas glucose-free perfusate alone or with 20 mM 2-deoxyglucose or 10-4 M IAA present only partially suppressed (by 41-59%) the increase in lactate output during hypoxia (Table  III) . The consequences of even partially blunting the ability of glycolysis to accelerate during hypoxia were profound. Compared to hypoxia with glucose present, during hypoxia without glucose tension suppression was more complete, contracture tension developed earlier, [KJ] o accumulation was greater, and cellular high energy phosphates were more rapidly depleted ( Fig. 8 and Table III) . If, in addition to removing glucose, 2-deoxyglucose or IAA were added to the perfusate, the deterioration in cardiac function during hypoxia was even more severe, as manifested by complete loss of twitch tension, severe irreversible contracture, large [K+] o accumulation, marked action potential shortening leading to inexcitability, and severe depletion of high energy phosphates (Table III) .
Results

Fig
Discussion
Evidence that high energy phosphates generated by glycolysis were used preferentially to support membrane function has Similarly, in cultured neonatal rat heart cells it has been shown that the susceptibility of the sarcolemmal membrane to damage by phospholipases (which have been incriminated in the pathogenesis of ischemic damage to the sarcolemma) was enhanced when glycolysis was inhibited, but not when oxidative metabolism was suppressed, despite similar levels of total cellular high energy phosphates (8) . Recently, Hasin and Barry (10) reported that in cultured chick embryo myocytes, membrane depolarization and 42K-uptake were more sensitive to selective inhibition of glycolytic than oxidative metabolism, despite a smaller depression of high energy phosphates in the former case. Conversely, contractile amplitude was much more sensitive to inhibition of oxidative metabolism. From these studies it has been postulated that high energy phosphates derived from glycolysis are preferentially used by the cardiac sarcolemma and help to prevent irreversible damage during insults such as ischemia. The results of the present study both confirm and extend these findings. Using cellular K+ loss as a marker of sarcolemmal function, we showed that suppression of glycolysis using 10-3 M IAA (in glucose-free perfusate containing pyruvate as substrate for oxidative metabolism) resulted in marked K+ loss, while causing only a modest suppression of twitch tension (Figs. 2 and 3) . Total cellular content of high energy phosphates was normal, presumably because oxidation of exogenous pyruvate and endogenous fatty acids allowed oxidative metabolism to compensate for the reduced contribution of glycolysis to the total high energy phosphate pool. In contrast, inhibition of oxidative metabolism with hypoxia, DNP, or Na azide caused only a modest K+ loss but markedly suppressed tension. Despite the marked degree of contractile dysfunction with 10-5 M DNP and lo-3 M Na azide (Figs. 1 and 3) , total cellular levels of high energy phosphates remained normal, presumably due to enhanced glycolysis (Table I and Fig. 7) . During more complete suppression of oxidative metabolism with hypoxia or higher doses of DNP (2.5 X 10'-M), total cellular content of higher energy phosphates did decrease as a result of the inability of glycolysis to compensate fully, and although twitch tension was further suppressed, K~loss still did not increase greatly (Table I) .
Our interpretation of these findings is that during inhibition of glycolysis, despite normal total cellular levels of high energy phosphates, high energy phosphates generated oxidatively were not effectively used by the sarcolemma to prevent K+ loss; conversely, during suppression of oxidative metabolism, high energy phosphates generated via glycolysis were not effectively used to maintain twitch tension despite (in the case of DNP and Na azide) normal total cellular levels of high energy phosphates. This functional compartmentation of glycolytic vs. oxidative metabolism is only partial, since simultaneous inhibition of both metabolic pathways had much more severe consequences on sarcolemmal and contractile function than that produced by inhibition of either pathway alone (Table  III) , as has been observed in other preparations (23) . For example, if glycolytically generated high energy phosphates could not be used at all by the contractile apparatus (complete compartmentation), then one would expect hypoxia alone to have had the same effect on mechanical performance as hypoxia and inhibition of glycolysis, i.e., complete loss of developed tension and severe contracture, which was not observed. Finally, it should be noted that under our experimental conditions, glucose and pyruvate were the only exogenous substrates supplied to the heart. It is possible that if other substrates, e.g., free fatty acids, were present, the evidence suggesting compartmentation could not be elicited.
The validity of interpreting our findings as evidence of compartmentation rests on two assumptions: first, that the methods used to suppress glycolytic and oxidative metabolism were selective and did not have major nonspecific effects on cellular K+ balance or tension development, and second, that the changes in cellular K+ loss and tension development were directly related to metabolic factors and not to secondary factors such as intracellular pH changes. Regarding the specifically of the metabolic inhibitors, the essentially similar results obtained with hypoxia, DNP, and Na azide on K+ loss and tension development, despite different mechanisms of mito- chrondial inhibition, suggest that their effects were related specifically to the suppression of oxidative metabolism and not to nonspecific actions of these agents on cardiac performance. IAA is a general sulfhydryl group inhibitor in high concentrations which may suppress many enzyme systems (24) . At the lo-3 M dosage and 10-min exposure period used in this study, however, total cellular levels of high energy phosphates remained normal, and the only detectable metabolic effect was a decrease in lactate output consistent with a suppression of glycolysis. 10-3 M IAA also had no direct effect on Na'-K' ATPase (Tables II and III) . Furthermore, if the dosage of IAA was reduced to lo-4 M so that the suppression of both basal lactate efflux rate (Table II) and the increase in lactate efflux rate in response to hypoxia (Table III) was comparable to the interventions listed above, the magnitude of [K+Io accumulation was similar to the other interventions (Table III) . Thus, in comparison to the other interventions suppressing glycolysis, IAA did not appear to have any nonspecific effect on K' loss out of proportion to its effect on glycolysis. However, we cannot absolutely exclude a nonspecific effect of IAA on K' permeability which would invalidate our interpretation of the findings.
The second criticism of interpreting our results in terms of compartmentation of metabolic energy relates to whether the changes in cellular K' balance and tension were caused directly by metabolic factors or were related to secondary factors, such as intracellular pH changes. The role of acidosis was evaluated in the experiments described in Figs. 8 and 9 , and it was concluded that the opposite effects of inhibition of glycolytic vs. oxidative metabolism on pH were unlikely to account for the results. It can be argued that extracellular pH measurements may not have accurately reflected changes in intracellular pH during these interventions. Direct intracellular pH measurements using 31P NMR, however, show good agreement with our extracellular pH measurements under similar conditions. Matthews et al. (25) , for example, found that after 10 min of hypoxia with glucose present as substrate, pHi decreased by 0.14 U in the Langendorff rat heart compared with the extracellular pH fall of 0.17 U we measured in the septum. There is considerable evidence supporting a direct link between cellular K' balance and metabolic state. The activity of the Na+-K+ pump obviously depends directly on the availability of ATP. However, during metabolic insults such as ischemia and hypoxia, several investigators have suggested that increased K' efflux rather than decreased K' influx is the more important factor causing cellular K' loss (10, 26-28).
Consistent with this hypothesis, two groups of investigators using the patch clamp technique in isolated ventricular cells have recently shown that a sarcolemma K+ channel becomes highly permeable when ATP content is reduced to low levels or removed from the perfusate (29, 30) . These observations suggest that cellular K+ loss during inhibition of metabolism is not a mere bystander phenomenon, but has a direct metabolic basis. It is likely that contractile dysfunction during hypoxia and other interventions also has a direct metabolic basis, especially since acidosis (the leading alternative) was excluded as a major factor (Fig. 8) . However, the precise etiology of contractile dysfunction during metabolic inhibition is not fully understood at the present time. Action potential configuration is determined by membrane ionic conductance changes, which are not thought to be direct energy consuming processes, with the possible exception of the slow Ca"+ channel (31) . Therefore, it is not surprising that changes in action potential duration did not parallel changes in K+ loss during metabolic inhibition (Fig. 3) It may be speculated that the close proximity of the mitochondria to the myofibrils enhances the delivery of oxidatively generated high energy phosphates to the contractile apparatus relative to high energy phosphates generated by other metabolic pathways. Although still controversial, it has been proposed that the phosphocreatine energy shuttle, whereby ATP generated intramyocardially is released into the cytosol in the form of phosphocreatine, may be the preferential source of ATP delivery to the contractile apparatus via the interaction of phosphocreatine with myosin-bound creatine kinase (2, 20, 21) . If this model is correct, the ability of glycolytically generated ATP to supply the contractile apparatus might be more limited, due to its lesser proximity and the possibility that cytosolic ATP is not as readily convertible to phosphocreatine as mitochondrially generated ATP, as has been reported in skeletal muscle (2) . Conversely, strategically positioned glycolytic enzymes could result in more efficient delivery of high energy phosphates to sites of utilization in the sarcolemma, accounting for the lesser ability of oxidatively generated high energy phosphates to preserve normal sarcolemmal integrity as manifested by K+ loss. In erythrocytes, evidence has been presented suggesting that membrane-bound glycolytic enzymes may be a preferential source of ATP delivery to the Na'-K' pump (1). Glycogenolytic enzyme complexes also have been demonstrated to be bound to the sarcoplasmic reticulum in cardiac muscle (32) . These mechanisms could potentially account for the functional compartmentation of glycolytic vs. oxidative mechanism we have observed in the rabbit ventricle.
The degree of compartmentation in this preparation is not complete, since inhibition of glycolysis led to some loss of tension and inhibition of oxidative metabolism caused some K+ loss. It might appear paradoxical that there should be any K+ loss during suppression of oxidative metabolism, since glycolytic flux is so greatly increased (Fig. 7) . It is possible that the K+ loss under these conditions is due not to a membrane conductance change, but is coupled to the movement of intracellular generated anions (e.g., lactate) from the intracellular to extracellular compartment, so that neutral charge balance is maintained across the sarcolemma. However, voltage clamp studies have identified an increase in background K+ conductance during hypoxia in cat papillary muscles (33) , which suggests that a change in sarcolemma K+ conductance contributes directly to K+ loss. A second possibility is that during inhibition of oxidative metabolism the increase in glycolytic flux also involves activation ofglycolytic enzymes not associated specifically with the sarcolemma (e.g., cytosolic or sarpoplasmic reticulum bound), so that competition for substrate limits ATP synthesis by the fraction of glycolytic enzyme specifically associated with the sarcolemma. This hypothesis implies a further compartmentation of glycolytic metabolism in the sense that not all glycolytically generated ATP would have the same preferential access to sites of use by the sarcolemma to prevent K+ loss. The observation that 10-3 M IAA consistently produced an irreversible contracture, beginning after an average of 4.0±2.2 min, may support this hypothesis. After prolonged exposure to hypoxia, contracture also develops, and occurs much sooner in the absence of exogenous glucose (34) . Like the hypoxia-induced contracture (35) , lowering [Ca++] o did not relax the IAA-induced contracture, which potentially indicates a similar mechanism. A feature common to these interventions producing contracture may be the suppression of glycogenolysis, directly in the case of 10-3 M IAA and by depletion of glycogen stores in the case of hypoxia without exogenous substrate. In view of the close association of glycogenolytic enzyme complexes with the sarcoplasmic reticulum in heart (32), it is conceivable that glycogenolysis preferentially supplies ATP to the relaxing system. A functional compartmentation of ATP generated from exogenous glucose vs. endogenous glycogen has been already demonstrated in vascular smooth muscle (36), and Dennis et al. (37) have previously postulated a similar phenomenon in cardiac muscle in order to explain the difference in reperfusion arrhythmias between glucose and pyruvate perfused hearts. We are currently investigating this possibility in the septal preparation.
